Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Solventum Corp’s stock clocked out at $71.82, down -2.14% from its previous closing price of $73.39. In other words, the price has decreased by -$2.14 from its previous closing price. On the day, 0.83 million shares were traded. SOLV stock price reached its highest trading level at $73.23 during the session, while it also had its lowest trading level at $71.535.
Ratios:
To gain a deeper understanding of SOLV’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 84.71. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 2.14 whereas as Long-Term Debt/Eq ratio is at 2.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Jefferies on September 11, 2025, initiated with a Hold rating and assigned the stock a target price of $80.
On July 15, 2025, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $103.
Argus Upgraded its Hold to Buy on July 01, 2025, while the target price for the stock was maintained at $90.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’25 when 3M CO sold 8,800,000 shares for $73.45 per share. The transaction valued at 646,360,000 led to the insider holds 25,569,190 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SOLV now has a Market Capitalization of 12452711424 and an Enterprise Value of 19775711232. As of this moment, Solventum’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.08, and their Forward P/E ratio for the next fiscal year is 11.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 21.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.48 while its Price-to-Book (P/B) ratio in mrq is 3.42. Its current Enterprise Value per Revenue stands at 2.358 whereas that against EBITDA is 14.435.
Stock Price History:
The Beta on a monthly basis for SOLV is 0.65, which has changed by 0.05462551 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, SOLV has reached a high of $85.92, while it has fallen to a 52-week low of $60.70. The 50-Day Moving Average of the stock is -1.53%, while the 200-Day Moving Average is calculated to be -0.87%.
Shares Statistics:
It appears that SOLV traded 1.01M shares on average per day over the past three months and 1279270 shares per day over the past ten days. A total of 173.39M shares are outstanding, with a floating share count of 147.50M. Insiders hold about 14.93% of the company’s shares, while institutions hold 67.09% stake in the company. Shares short for SOLV as of 1756425600 were 4266978 with a Short Ratio of 4.24, compared to 1753920000 on 3767496. Therefore, it implies a Short% of Shares Outstanding of 4266978 and a Short% of Float of 3.0700000000000003.
Earnings Estimates
The dynamic stock of Solventum Corp (SOLV) is currently attracting attention from 7.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $1.47, with high estimates of $1.51 and low estimates of $1.43.
Analysts are recommending an EPS of between $5.99 and $5.88 for the fiscal current year, implying an average EPS of $5.95. EPS for the following year is $6.3, with 9.0 analysts recommending between $6.65 and $6.1.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $2.05B. It ranges from a high estimate of $2.08B to a low estimate of $1.95B. As of. The current estimate, Solventum Corp’s year-ago sales were $2.08BFor the next quarter, 7 analysts are estimating revenue of $1.96B. There is a high estimate of $1.98B for the next quarter, whereas the lowest estimate is $1.94B.
A total of 7 analysts have provided revenue estimates for SOLV’s current fiscal year. The highest revenue estimate was $8.28B, while the lowest revenue estimate was $7.77B, resulting in an average revenue estimate of $8.18B. In the same quarter a year ago, actual revenue was $8.25BBased on 7 analysts’ estimates, the company’s revenue will be $7.93B in the next fiscal year. The high estimate is $8.01B and the low estimate is $7.69B.
